In 2019, Laura formed an all Women Board with diverse subject matter expertise to launch Angels for Change (A4C). Together, they evangelize the mission of A4C in their personal and professional lives. Their passion for guardianship built Angels for Change, created a national movement, and saved lives impacted by the drug shortage crisis.

LAURA BRAY,
CHIEF CHANGE MAKER

Laura Bray is Chief Change Maker and founder of Angels for Change. Founded in October 2019, Angels for Change is a global volunteer supported non-profit organization dedicated to Ensuring Access to Life Saving Drugs. Their mission is to end drug shortages through advocacy, awareness, and a resilient supply chain.  

Since their founding Laura has advocated on behalf of patients on hold from treatment because of a lifesaving drug shortage and worked within the supply chain to build drug shortage awareness, proactive solutions, and resolve patient and hospital level shortages. 

Laura has worked as an Adjunct Business Professor at Hillsborough Community College in Tampa Florida from 2004 - 2023. Prior to Academia, Laura worked in Marketing Strategy and Small Business Consulting. She graduated from University of Florida with a BSBA and from University of South Florida with a MBA. She lives in Tampa, Florida with her husband, Mike, and their three children Shelby, Abby and Cooper. 


Volunteer Board of DIRECTORS


MELANIE BONANNO

Director of Advocacy
Founding Board Member

DIANE MASIELLO

Director of Communications Founding Board Member

ANNE THOMAS

Founding Board Member

MELISSA GRACE

Director of Finance
Founding Board Member

FLORENCIA NORRIS

Secretary
Founding Board Member

ANNE DINAPOLI BLOCK

Founding Board Member

STEPHANIE MARTIN

Director of Legal
Founding Board Member

ALISON WALTERS

Director of Operations
Founding Board Member

AUSTIN SIMON

Founding Board Member


Volunteer Advisory Board

The Advisory Board is made up of industry professionals passionate about Angel for Change’s mission and helping achieve our goals of ending life-saving drug shortages. Each diverse member possesses the highest personal and professional integrity and values, holds thoughtful leadership with strategic insight in their respective fields.


On leave of absence until January 2025

Carina Dolan

jody garey

JARROD HANDLEY